Genetic deletion of CD36 inhibited Treg-mediated immunological suppression of tumor-infiltrating lymphocytes and suppressed tumor growth without eliciting severe autoimmunity, providing promising prospects for cancer treatment [147]. The gene discussed is CD36; the disease is Autoimmunity.